Research for clinical validation of HER2 protein overexpression and gene amplification assay for salivary gland carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015960

Enrollment

Registered

2014-12-17

Start date

2014-11-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Salivary gland carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ?Treatment at Hokkaido University Hospital from January 1989 to September 2014 ?Diagnosis of salivary gland carcinoma

Exclusion criteria

Exclusion criteria: No tissue specimen for assay

Design outcomes

Primary

Measure	Time frame
Concordance rate of HER2 positivity between each assay	—

Secondary

Measure	Time frame
?Concordance rate of staining score between each immunohistochemistry ?Correlation of HER2/CEP17 ratio between FISH and DISH	—

Countries

Japan

Outcome results